Jun 18, 2020
Nephrologists Are Hesitant to Fully Embrace Janssen's INVOKANA Despite Being the First and Only SGLT2 Inhibitor with an FDA Indication to Treat Diabetic Kidney Disease
Oct 08, 2019
Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes Medicine
Sep 30, 2019
Diabetic kidney disease is a common and costly complication in patients with type 2 diabetes(1,2)
Jun 27, 2019
National Kidney Foundation Sponsors Workshop to Examine New Therapy for Diabetic Kidney Disease
Mar 27, 2019
Diabetic Nephropathy Pipeline Insight Report 2019: Pipeline (Under Development), Therapeutics Scenario and Growth Prospects
Oct 24, 2018
Variant Pharmaceuticals Announces Publication of Data Demonstrating 2-Hydroxypropyl-b-Cyclodextrin (2HPbCD) Protects Against Kidney Disease in Experimental Models of Alport Syndrome (AS) and Focal Segmental Glomerulosclerosis (FSGS)
Oct 08, 2018
Global Diabetic Nephropathy Market and Competitive Landscape Report 2018: Track Market Size, Competitor Drug Sales & Market Shares
Jul 15, 2018
Okayama University Research: Diabetic Kidney Disease: New Biomarkers Improve the Prediction of the Renal Prognosis
Jun 22, 2018
Proteomics International at American Diabetes Association 78th Scientific Sessions following new license deals for diabetic kidney disease predictive test in USA and Mexico
May 24, 2018
Diabetic Nephropathy (Insulin) Market to be Driven by Rising Occurrence of Diabetes and Growing Awareness for Diabetes Treatment: Radiant Insights, Inc.
Apr 12, 2018
INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Feb 05, 2018
Health AI Startup Medial EarlySign Predicts Which Diabetic Patients Will Suffer Kidney Damage Within One Year
Jun 12, 2017
New data presented by Prometic at ADA's Scientific Sessions validates PBI-4050's positive impact on kidneys in patients with diabetes and metabolic syndrome
May 30, 2017
Disease-Modifying Therapies: An Unmet Need for Patients with Diabetic Nephropathy